vimarsana.com

Latest Breaking News On - Cancer theranostics - Page 1 : vimarsana.com

MyJournals.org - Science - '[ASAP] Using Exonucleases for Aptamer Characterization, Engineering, and Sensing' (Accounts of Chemical Research)

MyJournals.org - Science - [ASAP] Using Exonucleases for Aptamer Characterization, Engineering, and Sensing (Accounts of Chemical Research)

Sensing-accounts-of-chemical-research
Cancer-theranostics-accounts-of-chemical-research
Using-exonucleases
Aptamer-characterization
Chemical-research
Steric-effect
Inorganic-chemistry
Cancer-theranostics

MyJournals.org - Science - '[ASAP] A Pseudo-2D Model of the Reaction: Competitive Adsorption Kinetics for High-Temperature Electrochemical Hydrogen-Pump-Based Membrane Technology' (Industrial & Engineering Chemistry Research)

MyJournals.org - Science - [ASAP] A Pseudo-2D Model of the Reaction: Competitive Adsorption Kinetics for High-Temperature Electrochemical Hydrogen-Pump-Based Membrane Technology (Industrial & Engineering Chemistry Research)

Cancer-theranostics-accounts-of-chemical-research
Temperature-electrochemical-hydrogen
Membrane-technology-industrial-engineering-chemistry-research
Competitive-adsorption-kinetics
Engineering-chemistry-research
Cancer-theranostics
Chemical-research
Organic-letters
Myjournals
Ournals
Latest

Sustainable Nanomedicine; An Eco-Friendly Approach to Healthcare

In this article, AZoNano discusses how sustainable nanomedicine is helping the healthcare sector take an eco-friendly transition.

Arzoo-purisep
Blog-trivitron-healthcare-solutions-medical-device-company
Green-energy
Translational-research
Does-sustainability-look-like
Sustainable-healthcare
Edward-booty
Sambucus-canadensis
With-taking
Sustainable-approach
Plant-based-gums
Mucilages-applications

Attralus to Present New Data on Its Amyloidosis Portfolio at the 2022 International Symposium on Amyloidosis

Attralus, Inc., a clinical stage biopharmaceutical company developing transformative medicines to improve the lives of patients with systemic amyloidosis, today

Germany
Heidelberg
Baden-wüberg
San-francisco
California
United-states
Arnt-kristen
Ashutosh-wechalekar
Luke-heagle
Christophe-sirac
Alan-stuckey
Manasi-balachandran

Attralus to Present New Data on Its Amyloidosis Portfolio

SAN FRANCISCO, Aug. 22, 2022 (GLOBE NEWSWIRE) Attralus, Inc., a clinical stage biopharmaceutical company developing transformative medicines to.

Germany
Heidelberg
Baden-wüberg
Arnt-kristen
Ashutosh-wechalekar
Christophe-sirac
Alan-stuckey
Manasi-balachandran
Emily-martin
J-steve-foster
Olivier-clerc
Neue-universit

vimarsana © 2020. All Rights Reserved.